この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2000/10/61 分で読めます
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Technical Amendment
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the biologics regulations to reincorporate a regulation that was inadvertently omitted. This action is being taken to improve the accuracy of the regulations.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →